These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24961048)

  • 1. The effect of angiotensin converting enzyme inhibition on effective renal plasma flow in patients with diffuse renal parenchymal diseases and hypertension.
    Zeravica R; Stosić Z; Ilincić B; Crnobrnja V; Jakovljević A; Mijović R
    Med Pregl; 2014; 67(3-4):78-82. PubMed ID: 24961048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The comparative characteristics of the renal protective properties of angiotensin-converting enzyme inhibitors and calcium channel blockers].
    Kolesnyk MO; Lapchyns'ka II; Hromova AIe; Kassyr KhI
    Lik Sprava; 2000; (3-4):11-5. PubMed ID: 10921249
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
    Patel TV; Williams GH; Fisher ND
    J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of benazepril monotherapy in subjects with hypertension associated with renal dysfunction.
    Reams GP; Lau A; Bauer JH
    J Clin Pharmacol; 1989 Jul; 29(7):609-14. PubMed ID: 2668351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hypertension in renal parenchymal diseases].
    Iversen BM; Kvam FI; Svarstad E
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2022-6. PubMed ID: 8766645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cilazapril on renal function and hormones in hypertensive patients with renal disease.
    Swainson CP; Walker RJ; Bailey RR
    Am J Med; 1989 Dec; 87(6B):83S-87S. PubMed ID: 2532467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do angiotensin converting enzyme and calcium channel blocker intervene in the progression of renal disease besides by lowering systemic hypertension?].
    Nagase M
    Nihon Rinsho; 1997 Aug; 55(8):2116-22. PubMed ID: 9284433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trandolapril, but not verapamil nor their association, restores the physiological renal hemodynamic response to adrenergic activation in essential hypertension.
    Lambertucci L; Di Serio C; Castellani S; Torrini M; Lotti E; Cristofari C; Masotti G; Marchionni N; Ungar A
    Transl Res; 2011 Jun; 157(6):348-56. PubMed ID: 21575919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
    Götz R; Heidbreder E; Heidland A
    Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of angiotensin-converting enzyme inhibitors in chronic diffuse kidney diseases].
    Kutyrina IM; Tareeva IE; Gerasimenko OI; Rogov VA; Miroshnichenko NG
    Ter Arkh; 1995; 67(5):20-3. PubMed ID: 7638769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin converting enzyme inhibitors in renal diseases].
    Shestakova MV; Kutyrina IM
    Kardiologiia; 2002; 42(9):74-9. PubMed ID: 12494080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
    Cooke HM; De Besse A
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril-induced changes in effective renal plasma flow in hypertensive renal transplant recipients.
    Sud K; Oomen R; Jacob CK; Shastry JC
    Clin Transplant; 1996 Aug; 10(4):337-40. PubMed ID: 8884105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.
    Reams GP; Bauer JH
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):207-19. PubMed ID: 2285613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
    Kwakernaak AJ; Roksnoer LC; Lambers Heerspink HJ; van den Berg-Garrelds I; Lochorn GA; van Embden Andres JH; Klijn MA; Kobori H; Danser AH; Laverman GD; Navis GJ
    PLoS One; 2017; 12(1):e0169258. PubMed ID: 28118402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors and renal function.
    Mimran A; Ribstein J
    J Hypertens Suppl; 1989 Sep; 7(5):S3-9. PubMed ID: 2681604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal hemodynamic changes induced by captopril and angiotensin-converting enzyme gene polymorphism.
    Mizuiri S; Hemmi H; Inoue A; Takano M; Kadomatsu S; Tanimoto H; Tanegashima M; Hayashi I; Fushimi T; Hasegawa A
    Nephron; 1997; 75(3):310-4. PubMed ID: 9069453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.